logo
Evenements et Concours - HealthTech Investor Days (HTID) by France Biotech.
Appel à candidature

Expire le 25/06/19
Restant : 0 jours
Localisation :
FC305F92-51B3-4E76-920F-773E1682A7BC Public

Welcome to the HealthTech Investor Days (HTID) by France Biotech.

Paris, June 24th & 25th 2019

A European business event under the High Patronage of Mr Emmanuel MACRON President of the French Republic and the support of the French Ministry for the Economy and Finance, Mr Bruno Le Maire.

For the first time, the European Life Sciences community is organizing a international business event to connect leading worldwide investors, pharmaceutical companies and European C-level executives innovative companies in HealthTech.

France Biotech has the ambition to make the city of Paris a European place for business meetings for international investors (European, American and Asian) and innovative HealthTech companies.

« Europe is a land of innovation in health with many start-up and SME’s looking for financing to make their innovations avalaible to patients and to meet the medical challenges of tomorrow. The objective of the HTID is to become a reference place for exchanges between European HealthTech companies, international investors and pharmaceutical groups », said Maryvonne Hiance, chairman of France Biotech

This HealthTech Investor Days, a European Business event, will take place in Paris on June 24th & 25th , under the High Patronage of Mr Emmanuel MACRON President of the French Republic and the support of the French Ministry for the Economy and Finance, Mr Bruno Le Maire.

The two-day event will feature thematic panel discussion and one-on-one metings intented for European HealthTech companies, worldwide investors and pharmaceutical companies.

European targeted companies:
This event is organized for private and listed European companies willing to address leading investors and looking to raise funds.

The HTID is targeting :

European listed innovative companies in HealthTech (biotech, medtech, digital-health) with a market-cap starting from around €20 million
An on-going Phase II minimum for private biotech companies
CE or FDA approved product for medtech companies
If your project meets our requirements, please complete our dedicated application form to submit an expression of interest.

This event takes place at the Peninsula Paris and includes:

Investors one-on-one meetings between innovative HealthTech companies and investors: French, European, American, Asian hedge funds, VC, banks for near and long-term investment;
Partnering one-on-one meetings with pharmaceuticals companies such as Servier, Sanofi , Ipsen, Guerbet, Pfizer, Takeda, Amgen …;
Conferences and thematic panel discussions on specific topics supervised by well-known international scientific Key Opinion Leaders;
Networking events with special guests on Monday and Tuesday evening.


BioTechHealthTech - BeautyTechMedTech
healtech biotech medtech event meetup investors

Autres opportunités de Evenements et Concours


Login